Heron's Way Ahead: Is There Further Upside? [Seeking Alpha]
Heron Therapeutics, Inc. (HRTX)
Last heron therapeutics, inc. earnings: 3/2 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
herontherapeutics.gcs-web.com/investor-home
Company Research
Source: Seeking Alpha
Summary Heron Therapeutics ( HRTX ) is an emerging biopharma with two drugs - SUSTOL and CINVANTI - both approved for preventing CINV or Chemotherapy-Induced Nausea and Vomiting. The company has had an excellent year, going up almost 3x on the basis of these approvals. However, what we like about HRTX is that it continues to help sustain that momentum by pushing reformulated drugs in the market. Its next drug candidate in line is HTX-011, a fixed-dose combination of the local anesthetic bupivacaine with the nonsteroidal anti-inflammatory drug (NSAID) meloxicam. As the company claims, using a low dose of meloxicam in the combo reduces inflammation after surgery and also regulates the post-operative acidic environment. This lets bupivacaine better penetrate the site and reduce postoperative pain as well as the need for opioid analgesics during the critical 72 hours after surgery. The market for this is huge, and while it is well-diversified by both generic and single ingredie
Show less
Read more
Impact Snapshot
Event Time:
HRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HRTX alerts
High impacting Heron Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HRTX
News
- Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Released Its First-Quarter Earnings: Here's What Analysts Think [Yahoo! Finance]Yahoo! Finance
- Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Heron Therapeutics, Inc. (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.MarketBeat
- Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates [Yahoo! Finance]Yahoo! Finance
- Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate UpdatesPR Newswire
HRTX
Earnings
- 5/7/24 - Beat
HRTX
Sec Filings
- 5/7/24 - Form 10-Q
- 5/7/24 - Form 8-K
- 4/29/24 - Form ARS
- HRTX's page on the SEC website